Point: why choose pulsed-dose-rate brachytherapy for treating gynecologic cancers?
Affiliation
Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom. Susan.Davidson@christie.nhs.ukIssue Date
2010-08-09T12:00:00Z
Metadata
Show full item recordCitation
Point: why choose pulsed-dose-rate brachytherapy for treating gynecologic cancers?, 8 (3):269-72 BrachytherapyJournal
BrachytherapyDOI
10.1016/j.brachy.2009.06.004PubMed ID
19643373Type
ArticleLanguage
enISSN
1538-4721ae974a485f413a2113503eed53cd6c53
10.1016/j.brachy.2009.06.004
Scopus Count
Related articles
- [Gynecologic intracavity brachytherapy of a high-dose intensity. A review of the literature].
- Authors: Bistolfi F, Papadia S, Scielzo G, Siragusa A, Leonardi S, Tomassini E, Grillo Ruggieri F, Guglielmi M, Brizzi C, Parietti E
- Issue date: 1988 Oct
- [The use of brachytherapy in gynecologic oncology].
- Authors: Kanaev SV, Turkevich VG, Baranov SB, Savel'eva VV
- Issue date: 2005
- [Fractionated short-term afterloading with high dosage rates in the treatment of gynecologic tumors].
- Authors: Glaser FH, Grimm D, Hänsgen G, Rauh G, Heider KM, Kraft M, Salewski D, Schuchardt V
- Issue date: 1982
- [Current methods in brachytherapy of female genital malignancies].
- Authors: Kanaev SV, Turkevich VG, Baranov SB
- Issue date: 1997